CPRX - CATALYST PHARMACEUTICALS, INC.
IEX Last Trade
21.38
0.030 0.140%
Share volume: 19,641
Last Updated: Fri 27 Dec 2024 08:30:02 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.25%
PREVIOUS CLOSE
CHG
CHG%
$21.35
0.03
0.14%
Summary score
56%
Profitability
74%
Dept financing
4%
Liquidity
66%
Performance
49%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
7.42%
Return on assets
6.25%
Return on sales
34.81%
Return on invested capital
178.11%
Total debt ratio
13.76%
Debt ratio change over timeo
-0.8%
Current Ratio
7.01%
Quick Ratio
6.77%
Cash Position Ratio
6.07%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
3.59%
Return on assets
3.65%
Return on sales
18.98%
Return on invested capital
10.13%
Total debt ratio
15.45%
Debt ratio change over timeo
-0.58%
Current Ratio
3.97%
Quick Ratio
3.77%
Cash Position Ratio
2.8%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
4.15%
Return on assets
4.19%
Return on sales
27.54%
Return on invested capital
14.32%
Total debt ratio
13.18%
Debt ratio change over time
-0.34%
Current Ratio
5.09%
Quick Ratio
4.83%
Cash Position Ratio
3.9%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.38%
Return on assets
-84.55%
Return on sales
-25.54%
Return on invested capital
18.38%
Total debt ratio
-80.44%
Debt ratio change over time
-0.8%
Current Ratio
6.26%
Quick Ratio
5.92%
Cash Position Ratio
4.89%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CPRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 7.42% | 13.79% | 34.47% | 7.43% |
| Return on assets | 6.25% | 2.76% | 3.15% | 5.62% |
| Return on sales | 34.81% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 178.11% | 2.36% | 5.39% | 19.77% |
| Profitability | 77% | 39% | 58% | 56% |
| Total debt ratio | 13.76% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | -0.8% | 308.97% | -6.99% | 1.18% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 3.97% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.77% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.8% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 16% | 38% |
| Short-term ratios | CPRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 3.59% | 13.77% | 13.25% | 3.8% |
| Return on assets | 3.65% | 2.43% | 1.89% | 3.09% |
| Return on sales | 18.98% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 10.13% | 2.14% | 3.39% | 9.18% |
| Profitability | 72% | 67% | 65% | 76% |
| Total debt ratio | 15.45% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | -0.58% | 46.38% | -72.08% | 1.51% |
| Dept financing | 4% | 50% | 25% | 7% |
| Current Ratio | 3.97% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 3.77% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 2.8% | 0.36% | 1.28% | 2.93% |
| Liquididy | 63% | 12% | 31% | 75% |